FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to medicine and deal with mucosal vaccine, producing antigen-specific IgA of mucosa and IgG of blood at levels, capable of inducing effective immune induction and effect of infection prevention, which includes: (a) AD-carrier, consisting of synthetic peptide and mixture of dipalmitoylphosphatidylcholine, phosphatidylglycerol and palmitic acid; (b) carboxyvinyl polymer; and (c) antigenic protein. Group of inventions also deals with method of obtaining said mucosal vaccine.
EFFECT: group of inventions provides more powerful ability to produce antibodies than in mucosal vaccines of the present level of technology, resulting in excellent effect even with very small amount of antigen.
5 cl, 12 dwg, 5 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL ANTIGEN CARRIER ENABLING TRANSMUCOSAL AND TRANSDERMAL ADMINISTRATION, METHOD OF MUCOSAL IMMUNITY INDUCTION, MUCOSAL VACCINE AND RELATED DRUG DELIVERY SYSTEM | 2005 |
|
RU2396090C2 |
| SECRETORY IgA AND IgG ANTIBODY INDUCER | 2006 |
|
RU2440138C2 |
| PHARMACEUTICAL COMPOSITION BASED ON PLGA FOR THE INDUCTION OF THE EFFECTIVE MUCOSAL IMMUNE RESPONSE | 2018 |
|
RU2742580C2 |
| MUCOSAL INFLUENZA VIRUS VACCINE AND METHOD FOR INFLUENZA PREVENTION | 2004 |
|
RU2390351C2 |
| LIPOSOMES RENDERING THYMUS-DEPENDENT ASSISTANCE TO "WEAK" ANTIGENS USED FOR PREPARING VACCINE | 1993 |
|
RU2107493C1 |
| VACCINE COMPOSITION | 2013 |
|
RU2655627C2 |
| IMMUNOGENIC COMPOSITION CONTAINING SYNTHETIC PEPTIDES REPEATING SEQUENCE OF V3-LOOP OF SHELL PROTEIN GP120 HIV1 | 2017 |
|
RU2694576C2 |
| IMMUNE STIMULATING AND VACCINE COMPOSITIONS | 2011 |
|
RU2578420C2 |
| VACCINE COMPOSITIONS AND METHODS OF USE THEREOF | 2010 |
|
RU2600798C2 |
| FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPs) | 2006 |
|
RU2483751C2 |
